Regulation of cardiac adenylyl cyclase by Epidermal Growth Factor (EGF): Role of EGF receptor protein tyrosine kinase activity
- 5 October 1993
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 46 (7), 1239-1245
- https://doi.org/10.1016/0006-2952(93)90473-a
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Epidermal Growth Factor Produces Inotropic and Chronotropic Effects in Rat Hearts by Increasing Cyclic AMP AccumulationGrowth Factors, 1993
- Epidermal growth factor stimulates cAMP accumulation in cultured rat cardiac myocytesJournal of Cellular Physiology, 1992
- The inhibition of EGF-dependent proliferation of keratinocytes by tyrphostin tyrosine kinase blockers.The Journal of cell biology, 1991
- Epidermal growth factor stimulates rat cardiac adenylate cyclase through a GTP-binding regulatory proteinBiochemical Journal, 1989
- Protein phosphotyrosine phosphatase purified from the particulate fraction of human placenta dephosphorylates insulin and growth-factor receptorsBiochemical Journal, 1988
- Blocking of EGF-Dependent Cell Proliferation by EGF Receptor Kinase InhibitorsScience, 1988
- Ligand-induced endocytosis of the EGF receptor is blocked by mutational inactivation and by microinjection of anti-phosphotyrosine antibodiesCell, 1988
- Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routingCell, 1987
- PROTEIN-TYROSINE KINASESAnnual Review of Biochemistry, 1985
- A nonmitogenic analogue of epidermal growth factor induces early responses mediated by epidermal growth factor.The Journal of cell biology, 1982